AI system LiON detects liver malignancies in 10,333-patient trial

In the single-arm trial, LiON achieved an AUC of 0.952 (95% CI: 0.942–0.961) for malignancy diagnosis, meeting its primary endpoint. AI–human collaboration flagged 51 previously overlooked lesions (15 malignancies) and triggered 37 amended radiology reports.